Press Releases Latest Sep 26, 2023 Theratechnologies Reports Financial Results for the Third Quarter and Nine Months of Fiscal 2023 and Provides Business Updates Press Releases Year None20232022202120202019201820172016201520142013 Mar 25, 2013 Health Canada Decision Appealed Mar 04, 2013 Health Canada Issues Decision on Tesamorelin Feb 27, 2013 Theratechnologies Announces Financial Results for Fiscal Year 2012 Feb 14, 2013 Theratechnologies to Announce Financial Results for Fiscal Year 2012 Feb 05, 2013 Theratechnologies Announces Completion of NASDAQ Delisting Jan 29, 2013 Theratechnologies Secures US Patent for its Novel Peptide TH1173 Jan 21, 2013 FDA approves alternative storage conditions for EGRIFTA™ Jan 14, 2013 Theratechnologies Announces Intent to Voluntarily Delist from NASDAQ First page « Previous page ‹ … Page 25 Page 26 Page 27 Page 28 Page 29 Page 30 Page 31 Page 32 Current page 33 Displaying 321 - 328 of 328
Sep 26, 2023 Theratechnologies Reports Financial Results for the Third Quarter and Nine Months of Fiscal 2023 and Provides Business Updates
